Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients-Reference-Cited by-同舟云学术

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

Published:2017-02 Issue:2 Volume:58 Page:403-411
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Uher Tomas,Fellows Kelly,Horakova Dana,Zivadinov Robert,Vaneckova Manuela,Sobisek Lukas,Tyblova Michaela,Seidl Zdenek,Krasensky Jan,Bergsland Niels,Weinstock-Guttman Bianca,Havrdova Eva,Ramanathan Murali

Funder

National Multiple Sclerosis Society

Ministry of Health of the Czech Republic

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference38 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group;Neurology.,1993

2. Interferon beta in the treatment of multiple sclerosis: mechanisms of action;Yong;Neurology.,1998

3. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG);Jacobs;Ann. Neurol.,1996

4. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study;Comi;Lancet.,2001

5. Early treatment and dose optimisation BENEFIT and BEYOND;Hartung;J. Neurol.,2005

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid measures are associated with cognitive functioning in multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2024-11

2. Dyslipidemias in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-11

3. High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients;Scientific Reports;2024-07-13

4. Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis;Multiple Sclerosis and Related Disorders;2024-05

5. Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity;iScience;2024-03